163 related articles for article (PubMed ID: 33335407)
1. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1 [Retraction].
Onco Targets Ther; 2020; 13():12737. PubMed ID: 33335407
[TBL] [Abstract][Full Text] [Related]
2. lncRNA MAFG-AS1 Contributes to Esophageal Squamous-Cell Carcinoma Progression via Regulating miR143/LASP1.
Qu Y; Liu J
Onco Targets Ther; 2020; 13():8359-8370. PubMed ID: 32903907
[TBL] [Abstract][Full Text] [Related]
3. LncRNA MAFG-AS1 Accelerates Cell Migration, Invasion and Aerobic Glycolysis of Esophageal Squamous Cell Carcinoma Cells via miR-765/PDX1 Axis.
Qian CJ; Xu ZR; Chen LY; Wang YC; Yao J
Cancer Manag Res; 2020; 12():6895-6908. PubMed ID: 32801913
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MAFG-AS1 promotes the aggressiveness of breast carcinoma through regulating miR-339-5p/MMP15.
Li H; Zhang GY; Pan CH; Zhang XY; Su XY
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2838-2846. PubMed ID: 31002134
[TBL] [Abstract][Full Text] [Related]
5. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
Onco Targets Ther; 2022; 15():681-682. PubMed ID: 35733651
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MAFG-AS1 promotes proliferation, migration and invasion of hepatocellular carcinoma cells through downregulation of miR-6852.
Ouyang H; Zhang L; Xie Z; Ma S
Exp Ther Med; 2019 Oct; 18(4):2547-2553. PubMed ID: 31572506
[TBL] [Abstract][Full Text] [Related]
7. LncRNA EIF3J-AS1 functions as an oncogene by regulating MAFG to promote prostate cancer progression.
Ye C; Qin S; Guo F; Yang Y; Wang H; Zhang C; Yang B
J Cancer; 2022; 13(1):146-152. PubMed ID: 34976178
[TBL] [Abstract][Full Text] [Related]
8. MAFG-AS1 promotes tumor progression via regulation of the HuR/PTBP1 axis in bladder urothelial carcinoma.
Xiao M; Liu J; Xiang L; Zhao K; He D; Zeng Q; Zhang Q; Xie D; Deng M; Zhu Y; Zhang Y; Liu Y; Bo H; Liu X; Chen X; Gong L; Bao Y; Hu Y; Cheng Y; Deng L; Zhu R; Xing X; Zhou M; Xiong W; Zhou Y; Zhou J; Li X; Cao K
Clin Transl Med; 2020 Dec; 10(8):e241. PubMed ID: 33377647
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAFG-AS1 promotes the progression of colorectal cancer by sponging miR-147b and activation of NDUFA4.
Cui S; Yang X; Zhang L; Zhao Y; Yan W
Biochem Biophys Res Commun; 2018 Nov; 506(1):251-258. PubMed ID: 30348529
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/ CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance.
Feng J; Wen T; Li Z; Feng L; Zhou L; Yang Z; Xu L; Shi S; Hou K; Shen J; Han X; Teng Y
Aging (Albany NY); 2020 Oct; 12(20):20658-20683. PubMed ID: 33098638
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNA MAFG-AS1 Promotes Cell Proliferation, Migration, and EMT by miR-3196/STRN4 in Drug-Resistant Cells of Liver Cancer.
Chen T; Huang B; Pan Y
Front Cell Dev Biol; 2021; 9():688603. PubMed ID: 34386494
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MAFG-AS1 boosts the proliferation of lung adenocarcinoma cells via regulating miR-744-5p/MAFG axis.
Sui Y; Lin G; Zheng Y; Huang W
Eur J Pharmacol; 2019 Sep; 859():172465. PubMed ID: 31211984
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NOP14-AS1 Promotes Tongue Squamous Cell Carcinoma Progression by Targeting MicroRNA-665/HMGB3 Axis [Retraction].
Cancer Manag Res; 2022; 14():2733-2734. PubMed ID: 36148317
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis.
Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731
[TBL] [Abstract][Full Text] [Related]
17. HBx-upregulated MAFG-AS1 promotes cell proliferation and migration of hepatoma cells by enhancing MAFG expression and stabilizing nonmuscle myosin IIA.
Zhang F; Li Y; Gan L; Tong X; Qi D; Wang Q; Ye X
FASEB J; 2021 May; 35(5):e21529. PubMed ID: 33813778
[TBL] [Abstract][Full Text] [Related]
18. LOXL1-AS1 Drives the Progression of Gastric Cancer via Regulating miR-142-5p/PIK3CA Axis [Retraction].
Onco Targets Ther; 2023; 16():473-474. PubMed ID: 37396313
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15.
Jia YC; Wang JY; Liu YY; Li B; Guo H; Zang AM
Cell Biol Int; 2019 Apr; 43(4):384-393. PubMed ID: 30599080
[TBL] [Abstract][Full Text] [Related]
20. lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis [Retraction].
Onco Targets Ther; 2022; 15():133-134. PubMed ID: 35115788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
